Soiken Holdings (TSE:2385) Growth Rank: 1 (As of Sep. 21, 2026) — 89% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2385 Soiken Holdings Inc TSE:2385
57 GF Score
Price 円218.00
GF Value 円110.28
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Soiken Holdings Growth Rank?

Soiken Holdings TSE:2385 -0.91% 57 Growth Rank is 1 as of Sep. 21, 2026, which is 89% below its 10-year median of 9.00. GuruFocus rates TSE:2385 with a GF Score™ of 57/100 and a GF Value™ of 円110.28 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Soiken Holdings has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Soiken Holdings Growth Rank Related Terms

TSE:2385 vs VRTX, REGN, MRNA: Growth Rank Comparison

For the Biotechnology subindustry, Soiken Holdings's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Soiken Holdings Growth Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Soiken Holdings's Growth Rank distribution charts can be found below:

* The bar in red indicates where Soiken Holdings's Growth Rank falls into.


TSE:2385
57GF Score
Soiken Holdings Inc TSE:2385
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 1 mean?
Soiken Holdings (TSE:2385) has a Growth Rank of 1 as of Sep. 21, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Soiken Holdings and its competitors. This is 89% below median its historical median of 9.00. Over the past decade, Soiken Holdings' Growth Rank has ranged from 1.00 to 10.00.
Is Soiken Holdings' Growth Rank too high?
Soiken Holdings' current Growth Rank of 1 is 89% below median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Soiken Holdings has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soiken Holdings' Growth Rank compare to VRTX and REGN?
Soiken Holdings' Growth Rank of 1 can be compared against companies in the Biotechnology industry. Historically, Soiken Holdings' own Growth Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Biotechnology company?
A good Growth Rank depends on the Biotechnology industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Soiken Holdings and its competitors. Soiken Holdings's current Growth Rank is 1, which is 89% below median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soiken Holdings stock overvalued right now?
Based on GuruFocus' analysis, Soiken Holdings (TSE:2385) is currently considered Significantly Overvalued. The stock's GF Value™ is 円110.28, compared to a current price of 円218.00 — trading 97.7% above its estimated fair value. The current Growth Rank is 1, which is 89% below median its 10-year median of 9.00. Soiken Holdings' overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Soiken Holdings (TSE:2385), the current Growth Rank is 1 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Soiken Holdings (TSE:2385) Overvalued in 2026?

Based on GuruFocus' analysis, Soiken Holdings stock appears to be overvalued. The current stock price of 円218.00 is trading 97.7% above its estimated GF Value™ of 円110.28. GuruFocus considers Soiken Holdings to be Significantly Overvalued.

Key valuation signals for TSE:2385:

  • Growth Rank: 1 (89% below median its 10-year median of 9.00)
  • GF Value™: 円110.28 vs. price of 円218.00 (97.7% above fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the TSE:2385 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Soiken Holdings Business Description

Address 1-4-2 Shinsenri-Higashimachi, 13th Floor, Senri Life Science Center, Toyonaka, Osaka, JPN, 560-0082
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.
57GF Score

Get the complete analysis for TSE:2385

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円218.00
Price
円110.28
GF Value